On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
Some people need a short course, while others with long-term deficiency may require regular injections as advised by a healthcare professional
Ever feel like your internal battery is stuck at 20%
Pharmaceutical drugs undergo clinical trial phases to establish a therapeutic dose for human use
Scientific Sources Frequently Asked Questions Expand the questions below Once submitted, a state-licensed MD or DO will review your intake and determine the most appropriate treatment plan for you
Neural tube defect prevention in women of childbearing age unable to take oral folate